Ceftriaxone-resistant Salmonella septicemia and osteomyelitis in sickle cell disease adults

Southern Medical Journal

Volumn 99, Issue 6, 2006, Pages 625-627

  Morgan, James S ^a   Laber, Damian A ^a,b  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Bacteremia; Ceftriaxone resistance; Hemoglobinopathies; Osteomyelitis; Psoas abscess; Salmonella; Sickle cell

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN;

ADULT; ARTICLE; BACTEREMIA; BLOOD CULTURE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; FEVER; HUMAN; JAUNDICE; LEUKOCYTOSIS; MALE; MUCOSAL DRYNESS; OSTEOMYELITIS; PERCUTANEOUS DRAINAGE; PSOAS ABSCESS; SALMONELLA; SALMONELLOSIS; SEPTICEMIA; SICKLE CELL ANEMIA; TACHYCARDIA;

ADULT; ANEMIA, SICKLE CELL; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CEFTRIAXONE; CIPROFLOXACIN; COMORBIDITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OSTEOMYELITIS; PSOAS ABSCESS; SALMONELLA INFECTIONS; SALMONELLA PARATYPHI C; SEPSIS;

EID: 33745726033     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000220882.84566.9f     Document Type: Article

References (17)

1. Manci EA, Culberson DE, Yang YM, et al. Causes of death in sickle cell disease: an autopsy study. Br J Haematol 2003;123:359-365.
2. Onwubalili JK. Sickle cell disease and infection. J Infect 1983;7:2-20.
3. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364:1343-1360.
4. Tamouza R, Neonato MG, Busson M, et al. Infectious complications in sickle cell disease are influenced by HLA class II alleles. Hum Immunol 2002;63:194-199.
5. Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr 1986;109:579-585.
6. Norris CF, Smith-Whitley K, McGowan KL. Positive blood cultures in sickle cell disease: time to positivity and clinical outcome. J Pediatr Hematol Oncol 2003;25:390-395.
7. Wright J, Thomas P, Serjeant GR. Septicemia caused by Salmonella infection: an overlooked complication of sickle cell disease. J Pediatr 1997;130:394-399.
8. Almeida A, Roberts I. Bone involvement in sickle cell disease. Br J Haematol 2005;129:482-490.
9. Chambers JB, Forsythe DA, Bertrand SL, et al. Retrospective review of osteoarticular infections in a pediatric sickle cell age group. J Pediatr Orthop 2000;20:682-685.
10. Wong AL, Sakamoto KM, Johnson EE. Differentiating osteomyelitis from bone infarction in sickle cell disease. Pediatr Emerg Care 2001;17:60-63.
11. Skaggs DL, Kim SK, Greene NW, et al. Differentiation between bone infarction and acute osteomyelitis in children with sickle-cell disease with use of sequential radionuclide bone-marrow and bone scans. J Bone Joint Surg Am 2001;83-A:1810-1813.
12. Umans H, Haramati N, Flusser G. The diagnostic role of gadolinium enhanced MRI in distinguishing between acute medullary bone infarct and osteomyelitis. Magn Reson Imaging 2000;18:255-262.
13. Herikstad H, Hayes PS, Hogan J, et al. Ceftriaxone-resistant Salmonella in the United States. Pediatr Infect Dis J 1997;16:904-905.
14. Dunne EF, Fey PD, Kludt P, et al. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with ampC β-lactamase. JAMA 2000;284:3151-3156.
15. Fey PD, Safranek TJ, Rupp ME, et al. Ceftriaxone-resistant salmonella infection acquired by a child from cattle. N Engl J Med 2000;342:1242-1249.
16. Gupta A, Fontana J, Crowe C, et al. Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J Infect Dis 2003;188:1707-1716.
17. Miriagou V, Tassios PT, Legakis NJ, Tzouvelekis LS. Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella. Int J Antimicrob Agents 2004;23:547-555.